calendar
18,993 catalysts · 18,987 approval · 5,443 phase readout · 5,000 device 510k · 4,728 grant · 2,667 8k filing · 2,000 device pma
next 91 dayslessmore
MonWedFri
18,993 catalysts · 18,987 approval · 5,443 phase readout · 5,000 device 510k · 4,728 grant · 2,667 8k filing · 2,000 device pma
Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: LABS JUVISE. Form: CAPSULE. Route: ORAL
Sponsor: P AND L. Form: GUM, CHEWING. Route: BUCCAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: THEA PHARMA. Form: GEL. Route: OPHTHALMIC
Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LUPIN. Form: CAPSULE. Route: ORAL
Sponsor: CHIESI. Form: CAPSULE. Route: ORAL
Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: BIOVITRUM AB. Form: VIAL. Route: SUBCUTANEOUS
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL